Coverage
-
April 09, 2014
A Florida federal jury decided Wednesday that Novartis Pharmaceuticals Corp. didn't negligently fail to sufficiently warn a prescribing physician of the risks of jaw injuries allegedly caused by the bone drugs Aredia and Zometa, granting the company a victory in a sprawling product liability battle.
2 other articles on this case.
View all »